231 related articles for article (PubMed ID: 24202136)
21. Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis.
Millman S; Strauss AL; Parks JH; Coe FL
Kidney Int; 1982 Oct; 22(4):366-70. PubMed ID: 7176335
[TBL] [Abstract][Full Text] [Related]
22. Uric acid saturation in calcium nephrolithiasis.
Coe FL; Strauss AL; Tembe V; Le Dun S
Kidney Int; 1980 May; 17(5):662-8. PubMed ID: 7401461
[TBL] [Abstract][Full Text] [Related]
23. Etiological role of estrogen status in renal stone formation.
Heller HJ; Sakhaee K; Moe OW; Pak CY
J Urol; 2002 Nov; 168(5):1923-7. PubMed ID: 12394677
[TBL] [Abstract][Full Text] [Related]
24. Clinical and biochemical features of uric acid nephrolithiasis.
Ito H; Kotake T; Nomura K; Masai M
Eur Urol; 1995; 27(4):324-8. PubMed ID: 7656911
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and dietary factors of uric acid stone formation.
Trinchieri A; Montanari E
Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885
[TBL] [Abstract][Full Text] [Related]
26. Relative Supersaturation of 24-Hour Urine and Likelihood of Kidney Stones.
Prochaska M; Taylor E; Ferraro PM; Curhan G
J Urol; 2018 May; 199(5):1262-1266. PubMed ID: 29132983
[TBL] [Abstract][Full Text] [Related]
27. Dyslipidemia and kidney stone risk.
Torricelli FC; De SK; Gebreselassie S; Li I; Sarkissian C; Monga M
J Urol; 2014 Mar; 191(3):667-72. PubMed ID: 24055417
[TBL] [Abstract][Full Text] [Related]
28. Analysis of risk factors for uric acid nephrolithiasis in type 2 diabetes.
Hari Kumar KV; Modi KD
Saudi J Kidney Dis Transpl; 2011 May; 22(3):482-7. PubMed ID: 21566304
[TBL] [Abstract][Full Text] [Related]
29. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
Sakhaee K; Adams-Huet B; Moe OW; Pak CY
Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
[TBL] [Abstract][Full Text] [Related]
31. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
32. [Metabolic syndrome and nephrolithiasis].
Kohjimoto Y; Iba A; Sasaki Y; Hara I
Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
[TBL] [Abstract][Full Text] [Related]
33. Essential arterial hypertension and stone disease.
Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
[TBL] [Abstract][Full Text] [Related]
34. Obesity and urolithiasis: evidence of regional influences.
Trinchieri A; Croppi E; Montanari E
Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
[TBL] [Abstract][Full Text] [Related]
35. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
[TBL] [Abstract][Full Text] [Related]
36. Effect of BMI and urinary pH on urolithiasis and its composition.
Najeeb Q; Masood I; Bhaskar N; Kaur H; Singh J; Pandey R; Sodhi KS; Prasad S; Ishaq S; Mahajan R
Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):60-6. PubMed ID: 23354193
[TBL] [Abstract][Full Text] [Related]
37. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
[TBL] [Abstract][Full Text] [Related]
38. Metabolic syndrome and uric acid nephrolithiasis.
Sakhaee K; Maalouf NM
Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
[TBL] [Abstract][Full Text] [Related]
39. Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.
Cheungpasitporn W; Erickson SB; Rule AD; Enders F; Lieske JC
J Urol; 2016 May; 195(5):1476-1481. PubMed ID: 26598423
[TBL] [Abstract][Full Text] [Related]
40. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis.
Pak CY; Poindexter JR; Peterson RD; Koska J; Sakhaee K
Urology; 2002 Nov; 60(5):789-94. PubMed ID: 12429297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
